Loading clinical trials...
Loading clinical trials...
Randomised, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed-Dose Study of Escitalopram in Combination With Two Fixed Doses of Gaboxadol Compared to Escitalopram in Major Depressive Disorder
Conditions
Interventions
Escitalopram placebo
Gaboxadol placebo
+3 more
Locations
22
Austria
AT001
Vienna, Austria
RU019
Barnaul, Russia
RU029
Izhevsk, Russia
RU020
Kemerovo, Russia
RU012
Krasnodar, Russia
RU010
Krasnodar, Russia
Start Date
November 1, 2008
Primary Completion Date
December 1, 2009
Completion Date
February 1, 2010
Last Updated
December 17, 2012
NCT07115329
NCT06793397
NCT07025720
NCT06780917
NCT04480918
NCT05017311
Lead Sponsor
H. Lundbeck A/S
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions